Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb (BMY)
NYSE:BMY
Bristol-Myers Squibb (BMY) Ownership Overview
0.05% Insiders
21.63% Mutual Funds
16.24% Other Institutional Investors
24.27% ETFs
37.81% Public Companies and
Individual Investors
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail, and individual investors. Approximately 62.14% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 37.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 21, 2025 | Christopher Boerner Ceo,director | xxxxxxxxxxxxx | $110080 |
| Feb 19, 2025 | Samit Hirawat Evp,chief Med.offr.,drug Dev | xxxxxxxxxxxxx | $99973 |
| Nov 05, 2024 | Phil M Holzer Svp & Controller | xxxxxxxxxxxxx | $38927 |
| Nov 05, 2024 | Samit Hirawat Evp,chief Med.offr.,drug Dev | xxxxxxxxxxxxx | $100046 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $39592 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $539582 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1129276 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1377066 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 166,545,118 | Institution | 8.21% | 9,827,827,413 | |
| 138,066,234 | Institution | 6.80% | 8,147,288,468 | |
| 86,737,645 | Institution | 4.27% | 5,118,388,431 | |
| 77,754,059 | Institution | 3.83% | 4,588,267,022 | |
| 55,152,382 | Institution | 2.72% | 3,254,542,062 | |
| 33,733,998 | Institution | 1.66% | 1,990,643,222 | |
| 22,773,180 | Institution | 1.12% | 1,343,845,352 | |
| 20,921,111 | Institution | 1.03% | 1,234,554,760 | |
| 17,129,229 | Institution | 0.84% | 1,010,795,803 | |
| 15,857,429 | Institution | 0.78% | 935,746,885 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 138,066,234 | Institution | 6.80% | 8,147,288,468 | |
| 33,733,998 | Institution | 1.66% | 1,990,643,222 | |
| 15,857,429 | Institution | 0.78% | 935,746,885 | |
| 13,841,935 | Institution | 0.68% | 816,812,584 | |
| 12,584,180 | Institution | 0.62% | 742,592,462 | |
| 11,811,539 | Institution | 0.58% | 696,998,916 | |
| 10,367,907 | Institution | 0.51% | 611,810,192 | |
| 10,310,442 | Institution | 0.51% | 608,419,182 | |
| 9,296,007 | Institution | 0.46% | 548,557,373 | |
| 9,056,095 | Institution | 0.45% | 534,400,166 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 63,958,314 | Institution | 3.15% | 3,813,194,681 | |
| 56,250,638 | Institution | 2.77% | 3,353,663,038 | |
| 49,280,306 | Institution | 2.43% | 2,970,616,846 | |
| 25,605,655 | Institution | 1.26% | 1,510,989,702 | |
| 25,597,311 | Institution | 1.26% | 1,543,005,907 | |
| 23,057,001 | Institution | 1.14% | 1,360,593,629 | |
| 17,511,049 | Institution | 0.86% | 1,044,008,741 | |
| 14,662,922 | Institution | 0.72% | 883,880,938 | |
| 9,317,323 | Institution | 0.46% | 561,648,230 | |
| 8,743,952 | Institution | 0.43% | 527,085,427 |
FAQ
Who Owns Bristol-Myers Squibb (BMY)?
According to the latest TipRanks data, approximately 16.24% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 37.81% is held by retail investors.
What percentage of Bristol-Myers Squibb (BMY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.24% of Bristol-Myers Squibb (BMY) stock is held by institutional investors.
What percentage of Bristol-Myers Squibb (BMY) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.81% of Bristol-Myers Squibb (BMY) stock is held by retail investors.
Who owns the most shares of Bristol-Myers Squibb (BMY)?
Vanguard owns the most shares of Bristol-Myers Squibb (BMY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.